We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$36.9B
AUM Growth
+$1.94B
Cap. Flow
+$154M
Cap. Flow %
0.42%
Top 10 Hldgs %
4.62%
Holding
3,025
New
132
Increased
1,201
Reduced
1,478
Closed
188

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$57.1M
2
INCY icon
Incyte
INCY
+$53M
3
SD icon
SandRidge Energy
SD
+$46.7M
4
SNPS icon
Synopsys
SNPS
+$46.3M
5
AMD icon
Advanced Micro Devices
AMD
+$41.3M

Sector Composition

Rank Sector Weight
1 Technology 13.19%
2 Financials 13.13%
3 Healthcare 11.29%
4 Industrials 11.08%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIT
1301
DELISTED
CIT Group Inc.
CIT
$3.16M 0.01%
73,630
+2,719
+4% +$115K
YUMC icon
1302
Yum China
YUMC
$16.5B
$3.16M 0.01%
116,156
+32,679
+39% +$874K
IGHG icon
1303
ProShares Investment Grade-Interest Rate Hedged
IGHG
$330M
$3.16M 0.01%
41,428
-2,968
-7% -$226K
ICPT
1304
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.15M 0.01%
27,891
-10
-0% -$1.17K
CMO
1305
DELISTED
Capstead Mortgage Corp.
CMO
$3.15M 0.01%
299,077
+18,701
+7% +$197K
CATY icon
1306
Cathay General Bancorp
CATY
$4.22B
$3.15M 0.01%
83,649
-2,654
-3% -$101K
AWF
1307
AllianceBernstein Global High Income Fund
AWF
$870M
$3.15M 0.01%
250,383
-15,819
-6% -$201K
AX icon
1308
Axos Financial
AX
$5.77B
$3.15M 0.01%
120,464
-8,137
-6% -$235K
EGRX
1309
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.14M 0.01%
37,883
-1,392
-4% -$103K
ANDE icon
1310
Andersons Inc
ANDE
$2.41B
$3.14M 0.01%
82,928
+17,990
+28% +$695K
HZNP
1311
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.14M 0.01%
212,582
+12,121
+6% +$196K
IAE
1312
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$91.8M
$3.14M 0.01%
309,525
-56,696
-15% -$540K
VR
1313
DELISTED
Validus Hold Ltd
VR
$3.13M 0.01%
55,560
-7,412
-12% -$423K
BSD
1314
DELISTED
The BlackRock Strategic Municipal Trust
BSD
$3.13M 0.01%
233,408
-27,193
-10% -$368K
AMAG
1315
DELISTED
AMAG Pharmaceuticals
AMAG
$3.12M 0.01%
138,481
+11,925
+9% +$285K
ISCA
1316
DELISTED
International Speedway Corp
ISCA
$3.12M 0.01%
84,399
-7,011
-8% -$259K
PBF icon
1317
PBF Energy
PBF
$8.57B
$3.11M 0.01%
140,413
+67,069
+91% +$1.57M
GLBL
1318
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$3.11M 0.01%
648,112
-898,530
-58% -$4.06M
DPLO
1319
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$3.11M 0.01%
194,913
-39,282
-17% -$567K
TIVO
1320
DELISTED
Tivo Inc
TIVO
$3.1M 0.01%
165,566
-14,261
-8% -$273K
RARE icon
1321
Ultragenyx Pharmaceutical
RARE
$2.45B
$3.1M 0.01%
45,721
-1,496
-3% -$114K
SAM icon
1322
Boston Beer
SAM
$1.91B
$3.1M 0.01%
21,419
+8,166
+62% +$1.28M
PLCE icon
1323
Children's Place
PLCE
$54.3M
$3.09M 0.01%
25,736
-2,130
-8% -$225K
BNJ
1324
DELISTED
Blackrock New Jersey Muni Tr
BNJ
$3.09M 0.01%
208,997
-8,099
-4% -$118K
TX icon
1325
Ternium
TX
$9.67B
$3.09M 0.01%
118,189
-10,621
-8% -$264K

Similar funds

Guggenheim Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Guggenheim Capital held 3,025 positions worth $36.9B, up 5.5% from $35B the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

Guggenheim Capital's Q1 2017 filing shows 132 new, 1,201 increased, 1,478 reduced and 188 closed positions. Its largest new stake was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,177,888 shares worth $26.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $92.1M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q1 2017 buy was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,177,888 shares worth $26.2M.
  • Guggenheim Capital added most to Idexx Laboratories in Q1 2017, an estimated $57.1M increase.
  • Guggenheim Capital's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.1M.
  • Guggenheim Capital fully exited Linear Technology Corp in Q1 2017, selling an estimated $72.6M.
  • Guggenheim Capital's ten largest holdings make up 4.6% of its $36.9B portfolio in Q1 2017.
  • Guggenheim Capital opened 132 new positions and closed 188 in Q1 2017.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $36.9B.

Based on Guggenheim Capital's 13F filing for Q1 2017, filed 15 May 2017.